Antioxidant ·Emerging evidence ·Reviewed May 2026
Ellagic acid is a naturally occurring polyphenol found in pomegranates, walnuts, and many berries such as raspberries, strawberries, and blackberries. In the body it is largely derived from dietary ellagitannins and is further converted by gut bacteria into urolithins, which appear to account for many of its proposed effects. It is taken as a supplement for general antioxidant and cellular-health support, though human clinical evidence remains limited.
The bottom line
Evidence rating emerging. Most-documented uses: antioxidant and free-radical scavenging support, cellular and oxidative-stress defense, anti-inflammatory support. 9 sources indexed (2008–2018), with 5 interaction records on file.
Core mechanism
Ellagic acid acts primarily as a direct free-radical scavenger and metal chelator, neutralizing reactive oxygen species and reducing lipid peroxidation. It can upregulate endogenous antioxidant defenses through activation of the Nrf2 signaling pathway, increasing expression of enzymes such as glutathione peroxidase, superoxide dismutase, and catalase. In preclinical models it also modulates inflammatory signaling (for example NF-kB) and influences several enzymes involved in xenobiotic metabolism. Importantly, ellagic acid itself is poorly absorbed; much of its biological activity in vivo is attributed to gut-microbiota-derived urolithins (A and B), which have greater bioavailability and longer residence time.5,2
Ellagic acid has low oral bioavailability and is poorly water soluble; taking it with food may modestly aid tolerability. Much of its activity depends on conversion to urolithins by gut bacteria, and this conversion varies widely between individuals based on microbiome composition.1
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Pomegranate ellagitannin extract (standardized).
Budget and mid tiers reflect free ellagic acid or pomegranate ellagitannin extract capsules. The premium tier reflects direct urolithin A postbiotic products (e.g. branded Mitopure), which are substantially more expensive per effective dose but remove the microbiome-conversion uncertainty. Prices are approximate US retail and vary by standardization and brand. Updated 2026-06-04.
Dose: 250 to 500 mg pomegranate ellagitannin extract daily2,3
Timing: With a meal, once daily
Antioxidant effects are attributed largely to ellagitannin-derived urolithins. Evidence in humans is preliminary; treat as adjunctive, not a substitute for a polyphenol-rich diet.
Dose: 500 to 1000 mg urolithin A daily (or 500 mg pomegranate extract as a precursor)
Timing: With food, once daily
Mitophagy and muscle-endurance signals come from direct urolithin A trials; precursor forms only work in people whose microbiome converts ellagitannins to urolithins.
Dose: 250 to 500 mg pomegranate extract daily4
Timing: With a meal, daily
Whole pomegranate polyphenols have modest blood-pressure and endothelial signals; isolated ellagic acid evidence is weaker. Not a replacement for established cardiovascular therapy.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Ellagic acid is a hydrolyzable-tannin-derived polyphenol with direct free-radical scavenging activity and the ability to upregulate the Nrf2/ARE pathway, increasing endogenous antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase). Much of its in vivo activity is attributed to gut-microbiota conversion to urolithins, which support mitochondrial quality control via mitophagy.1
Most human evidence is on antioxidant biomarkers rather than hard clinical endpoints. Oral bioavailability of ellagic acid itself is low and highly variable; benefits depend substantially on individual microbiome capacity to produce urolithins.
Polyphenol-driven inhibition of NF-kB signaling and downregulation of pro-inflammatory cytokines (TNF-alpha, IL-6) and COX-2 expression in preclinical models may help dampen low-grade inflammatory signaling associated with joint discomfort.
Anti-inflammatory effects are largely demonstrated in cell and animal studies; robust human joint-outcome trials for ellagic acid specifically are lacking. Should not replace established care for inflammatory arthritis.
Ellagitannin-rich pomegranate polyphenols have been associated in some trials with improved endothelial function and reduced LDL oxidation, plausibly via antioxidant protection of the vascular endothelium and modulation of inflammatory tone. Effects on blood pressure and lipids are modest and inconsistent.1,5
Evidence is stronger for whole pomegranate preparations than for isolated ellagic acid. Not a substitute for statins, antihypertensives, or lifestyle measures.
Vitamin C is a water-soluble antioxidant that can regenerate other oxidized antioxidants and complements the free-radical scavenging and Nrf2-mediated effects of ellagic acid, providing overlapping antioxidant coverage.
Recommendation: These can reasonably be taken together for general antioxidant support; no special separation is required. There is no need to megadose either to obtain the additive effect.
Ellagic acid and the ellagitannins in pomegranate/berry extracts are polyphenols and tannins that chelate non-heme iron in the gut lumen, which can substantially reduce dietary and supplemental non-heme iron absorption when taken together.
Recommendation: Separate ellagic acid (and tannin-rich pomegranate/berry extracts) from iron supplements by at least 2 hours. This is especially important for people being treated for iron-deficiency anemia.
Both are polyphenols that converge on NF-kB and Nrf2 signaling, so combined use may provide complementary anti-inflammatory and antioxidant effects.
Recommendation: May be taken together for antioxidant/anti-inflammatory support. Take with food for tolerability; no separation needed.
Both ellagic acid (and its ellagitannin-rich source extracts) and green tea extract are concentrated polyphenols. Stacking multiple high-dose polyphenol extracts increases cumulative tannin/catechin load, which can compound mineral malabsorption and, in the case of high-dose green tea catechins, raises the theoretical hepatotoxicity burden.
Recommendation: Avoid stacking several high-dose polyphenol extracts at maximal doses. Keep green tea extract within recommended limits, take with food, and watch for GI upset. Separate both from iron and other mineral supplements.
Resveratrol and ellagic acid are both polyphenols with antioxidant and Nrf2-supporting activity, and may be used together for general cellular-health support.
Recommendation: Can be combined for antioxidant support with food; no time separation required. Modest, evidence-limited benefit expectations are appropriate.
Numbered references. Citations throughout the page link here.
Summarizes mechanisms by which ellagic acid scavenges reactive oxygen species and induces Nrf2-mediated antioxidant defenses in preclinical models.
Documents poor absorption of free ellagic acid and emphasizes that physiological effects largely depend on urolithin formation by the gut microbiome.
Describes microbial conversion of ellagitannins and ellagic acid into urolithins and the high interindividual variability in this process.
Reviews evidence that pomegranate-derived ellagic acid and ellagitannins display antioxidant activity, while noting limited bioavailability of ellagic acid itself.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
